$BLUE News Article - bluebird bio Receives Positive CHMP Opinion for SKYSONA(TM) (elivaldogene autotemcel, Lenti-D(TM)) Gene Therapy for Patients Less Than 18 Years of Age with Early Cerebral Adrenoleukodystrophy (CALD)
https://marketwirenews.com/news-releases/blue...03923.html